Literature DB >> 3121816

On the costs of treating mild hypertension.

A Gafni1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121816     DOI: 10.1007/bf02596376

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  10 in total

1.  Economic considerations in the management of mild hypertension.

Authors:  M C Weinstein; W B Stason
Journal:  Ann N Y Acad Sci       Date:  1978-03-30       Impact factor: 5.691

2.  The economic costs of the health effects of smoking, 1984.

Authors:  D P Rice; T A Hodgson; P Sinsheimer; W Browner; A N Kopstein
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

3.  The mild hypertension dilemma: results of the British MRC trial.

Authors:  W E Miall
Journal:  J Clin Hypertens       Date:  1986-09       Impact factor: 3.738

4.  Should mild hypertension be treated? An attempted meta-analysis of the clinical trials.

Authors:  H S Sacks; T C Chalmers; A A Berk; D Reitman
Journal:  Mt Sinai J Med       Date:  1985-04

5.  Cost-effectiveness of antepartum prevention of Rh immunization.

Authors:  G W Torrance; A Zipursky
Journal:  Clin Perinatol       Date:  1984-06       Impact factor: 3.430

6.  Public-health rounds at the Harvard School of Public Health. Allocation of resources to manage hypertension.

Authors:  W B Stason; M C Weinstein
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

7.  Diuretic therapy for mild hypertension: the "real" cost of treatment.

Authors:  D A McCarron
Journal:  Am J Cardiol       Date:  1984-01-27       Impact factor: 2.778

8.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

9.  Opportunities for improving the cost-effectiveness of antihypertensive treatment.

Authors:  W B Stason
Journal:  Am J Med       Date:  1986-12-31       Impact factor: 4.965

10.  Increased absenteeism from work after detection and labeling of hypertensive patients.

Authors:  R B Haynes; D L Sackett; D W Taylor; E S Gibson; A L Johnson
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

  10 in total
  1 in total

Review 1.  Cost considerations in the pharmacological prevention and treatment of stroke.

Authors:  A V Alexandrov; L T Smurawska; W Bartle; P Oh
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.